Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myrthe A M van Delft

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Autoimmunity|January 9, 2020
An overview of autoantibodies in rheumatoid arthritisMyrthe A M van Delft, Tom W J Huizinga
European Journal of Clinical Investigation|March 5, 2015
The contribution of NF-κB signalling to immune regulation and toleranceMyrthe A M van Delft, Leonie F A Huitema, Sander W Tas
Annals of the Rheumatic Diseases|August 16, 2018
Secretory form of rheumatoid arthritis-associated autoantibodies in serum are mainly of the IgM isotype, suggesting a continuous reactivation of autoantibody responses at mucosal surfacesMyrthe A M van Delft, Diane van der Woude, René E M Toes, et al.
Clinical and Experimental Rheumatology|July 15, 2020
Anti-carbamylated protein antibodies: are they useful for the diagnosis of rheumatoid arthritis?Frederique Ponchel, Myrthe A M van Delft, Xuanxiao Xie, et al.
Frontiers in Immunology|April 21, 2023
Antagonizing FcαR1 (CD89) as treatment in IgA-mediated chronic inflammation and autoimmunityMyrthe A M van Delft, Esil Aleyd, Richard van der Mast, et al.
Arthritis Research & Therapy|December 4, 2016
Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohortsMichael Ziegelasch, Myrthe A M van Delft, Philip Wallin, et al.
Frontiers in Immunology|July 19, 2021
IgA Immune Complexes Induce Osteoclast-Mediated Bone ResorptionAnnelot C Breedveld, Melissa M J van Gool, Myrthe A M van Delft, et al.
Rheumatology (Oxford, England)|October 3, 2017
The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgiaRobin M Ten Brinck, Hanna W van Steenbergen, Myrthe A M van Delft, et al.
Rheumatology (Oxford, England)|June 29, 2020
Arthritis autoantibodies in individuals without rheumatoid arthritis: follow-up data from a Dutch population-based cohort (Lifelines)Johanna Westra, Elisabeth Brouwer, Elisabeth Raveling-Eelsing, et al.
Rheumatology (Oxford, England)|May 31, 2018
The anti-carbamylated protein antibody response is of overall low avidity despite extensive isotype switchingMyrthe A M van Delft, Marije K Verheul, Leonie E Burgers, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Autoimmunity|January 9, 2020
An overview of autoantibodies in rheumatoid arthritisMyrthe A M van Delft, Tom W J Huizinga
European Journal of Clinical Investigation|March 5, 2015
The contribution of NF-κB signalling to immune regulation and toleranceMyrthe A M van Delft, Leonie F A Huitema, Sander W Tas
Annals of the Rheumatic Diseases|August 16, 2018
Secretory form of rheumatoid arthritis-associated autoantibodies in serum are mainly of the IgM isotype, suggesting a continuous reactivation of autoantibody responses at mucosal surfacesMyrthe A M van Delft, Diane van der Woude, René E M Toes, et al.
Clinical and Experimental Rheumatology|July 15, 2020
Anti-carbamylated protein antibodies: are they useful for the diagnosis of rheumatoid arthritis?Frederique Ponchel, Myrthe A M van Delft, Xuanxiao Xie, et al.
Frontiers in Immunology|April 21, 2023
Antagonizing FcαR1 (CD89) as treatment in IgA-mediated chronic inflammation and autoimmunityMyrthe A M van Delft, Esil Aleyd, Richard van der Mast, et al.
Arthritis Research & Therapy|December 4, 2016
Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohortsMichael Ziegelasch, Myrthe A M van Delft, Philip Wallin, et al.
Frontiers in Immunology|July 19, 2021
IgA Immune Complexes Induce Osteoclast-Mediated Bone ResorptionAnnelot C Breedveld, Melissa M J van Gool, Myrthe A M van Delft, et al.
Rheumatology (Oxford, England)|October 3, 2017
The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgiaRobin M Ten Brinck, Hanna W van Steenbergen, Myrthe A M van Delft, et al.
Rheumatology (Oxford, England)|June 29, 2020
Arthritis autoantibodies in individuals without rheumatoid arthritis: follow-up data from a Dutch population-based cohort (Lifelines)Johanna Westra, Elisabeth Brouwer, Elisabeth Raveling-Eelsing, et al.
Rheumatology (Oxford, England)|May 31, 2018
The anti-carbamylated protein antibody response is of overall low avidity despite extensive isotype switchingMyrthe A M van Delft, Marije K Verheul, Leonie E Burgers, et al.
Pageof 2